Class IIOngoingD-1104-2023
Drug recall · August 30, 2023
All Over-The-Counter recall
Why: CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.
- Lots / codes
Miscellaneous
- Quantity
- Unknown
- Company
- Inmar Supply Chain Solutions, LLC, Arlington, TX
- Distribution
- Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.
- Initiated
- August 14, 2023 · N/A
- Classified
- August 24, 2023
- Reported
- August 30, 2023
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.